Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Assets Growth (1y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash from Operations (QoQ)Cash from Operations Growth (1y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Gross Profit (QoQ)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Share-based Compensation (QoQ)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)
Income Statement
Others
Bright Minds Biosciences (DRUG) Selling, General & Administrative: 2020-2021
Generated on {Timestamp}
© BusinessQuant.com
Generated on {Timestamp}
Powered by
Peer Comparison
Historic Data
Download Data 🔒| Date | Value |
|---|---|